CSCI welcomes new cohort of postgraduate students
8 December 2022
A total of 26 new Postgraduate students started at CSCI in October 2022, under the supervision of 11 different PIs within the Institute. These students are on a variety of PhD and Masters programmes, and are based in the following labs: Wellcome MRes + PhD Programme (currently doing rotations): 6 students CCMR MRes + PhD...
Off-patent liver disease drug could prevent COVID-19 infection
5 December 2022
Cambridge scientists from the Sampaziotis lab show that a widely used drug to treat liver disease can prevent COVID-19 infection or reduce disease severity Cambridge Stem Cell Institute scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future...
Stem Cells IRC workshop winners announced
18 November 2022
Winners from the Collaboration Creation Days workshop have been awarded this week for their proposals presented at the end of the event. In September, the Wellcome-MRC Cambridge Stem Cell Institute Interdisciplinary Research Centre , together with Sensor CDT , Cambridge Centre for Physical Biology , and the Department of...
7 November 2022
Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled...
Sign up to our newsletter to stay up to date with news and events from the Cambridge stem cell community.
Follow the 'Under the Microscope' newsletter from the lab of PI Dr Matthias Zilbauer
© 2022 University of Cambridge
